A landmark UK trial aiming to revolutionise prostate cancer screening has begun testing its first male participants. The ...

Prostate-cancer screening based on prostate-specific antigen (PSA) levels in the blood was introduced—and readily adopted—in the United States around the late 1980s. But this screening method, in ...

A team of researchers has constructed the most detailed single-cell map of the adult human prostate to date, cataloging more ...

Prostate cancer screening plans could be scaled back even further, despite growing calls for more testing to be rolled out.

The first men have been invited to take part in Prostate Cancer UK's TRANSFORM trial, kicking off the biggest prostate cancer screening study in a generation. The £42m trial is being co-led by UCL, ...

Fear of discomfort and unnecessary treatment often deters patients from prostate cancer screening, despite the benefits of early detection. Prostate cancer can be asymptomatic, making early detection ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

In a biopsy, a small sample of tissue is taken from your body. A pathologist analyzes the sample to check for cancer cells. The main method for diagnosing prostate cancer is a core needle biopsy. It’s ...

The first men have taken part in a major UK trial testing new ways to screen for prostate cancer and detect the disease earlier ...

A landmark trial aiming to shape the future of prostate cancer screening in the UK has begun testing a group of men ...